Literature DB >> 18382362

Cell-free DNA fragmentation patterns in amniotic fluid identify genetic abnormalities and changes due to storage.

Inga Peter1, Hocine Tighiouart, Olav Lapaire, Kirby L Johnson, Diana W Bianchi, Norma Terrin.   

Abstract

Circulating cell-free DNA (cfDNA) has become a promising biomarker in prenatal diagnosis. However, despite extensive studies in different body fluids, cfDNA predictive value is uncertain owing to the confounding factors that can affect its levels, such as gestational age, maternal weight, smoking status, and medications. Residual fresh and archived amniotic fluid (AF) supernatants were obtained from gravid women (mean gestational age 17 wk) carrying euploid (N=36) and aneuploid (N=29) fetuses, to characterize cfDNA-fragmentation patterns with regard to aneuploidy and storage time (-80 degrees C). AF cfDNA was characterized by the real-time quantitative polymerase chain reaction amplification of glyceraldehyde-3-phosphate dehydrogenase, gel electrophoresis, and pattern recognition of the DNA fragmentation. The distributions of cfDNA fragment lengths were compared using 6 measures that defined the locations and slopes for the first and last peaks, after elimination of the confounding variables. This method allowed for the unique classification of euploid and aneuploid cfDNA samples in AF, which had been matched for storage time. In addition, we showed that archived euploid AF samples gradually lose long cfDNA fragments: this loss accurately distinguishes them from the fresh samples. We present preliminary data using cfDNA-fragmentation patterns, to uniquely distinguish between AF samples of pregnant women with regard to aneuploidy and storage time, independent of gestational age and initial DNA amount. In addition to potential applications in prenatal diagnosis, these data suggest that archived AF samples consist of large amounts of short cfDNA fragments, which are undetectable using standard real-time polymerase chain reaction amplification.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382362      PMCID: PMC4459511          DOI: 10.1097/PDM.0b013e31815bcdb6

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  16 in total

1.  Large amounts of cell-free fetal DNA are present in amniotic fluid.

Authors:  D W Bianchi; E S LeShane; J M Cowan
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

2.  Down syndrome and cell-free fetal DNA in archived maternal serum.

Authors:  Thomas Lee; Erik S LeShane; Geralyn M Messerlian; Jacob A Canick; Antonio Farina; Walter W Heber; Diana W Bianchi
Journal:  Am J Obstet Gynecol       Date:  2002-11       Impact factor: 8.661

3.  Presence of fetal DNA in maternal plasma and serum.

Authors:  Y M Lo; N Corbetta; P F Chamberlain; V Rai; I L Sargent; C W Redman; J S Wainscoat
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

4.  Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels.

Authors:  Tuangsit Wataganara; Inga Peter; Geralyn M Messerlian; Lynn Borgatta; Diana W Bianchi
Journal:  Obstet Gynecol       Date:  2004-09       Impact factor: 7.661

5.  Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women.

Authors:  Keiko Koide; Akihiko Sekizawa; Mariko Iwasaki; Ryu Matsuoka; Susumu Honma; Antonio Farina; Hiroshi Saito; Takashi Okai
Journal:  Prenat Diagn       Date:  2005-07       Impact factor: 3.050

6.  Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?

Authors:  Ageliki Gerovassili; Chad Garner; Kypros H Nicolaides; Swee Lay Thein; David C Rees
Journal:  Prenat Diagn       Date:  2007-02       Impact factor: 3.050

7.  Cell-free fetal DNA in amniotic fluid: unique fragmentation signatures in euploid and aneuploid fetuses.

Authors:  Olav Lapaire; Diana W Bianchi; Inga Peter; Barbara O'Brien; Helene Stroh; Janet M Cowan; Umadevi Tantravahi; Kirby L Johnson
Journal:  Clin Chem       Date:  2007-01-26       Impact factor: 8.327

8.  Elevated cell-free serum DNA detected in patients with myocardial infarction.

Authors:  Christine P-Y Chang; Rhu-Hsin Chia; Tsu-Lan Wu; Kuo-Chien Tsao; Chien-Feng Sun; James T Wu
Journal:  Clin Chim Acta       Date:  2003-01       Impact factor: 3.786

9.  Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

Authors:  Y M Lo; M S Tein; T K Lau; C J Haines; T N Leung; P M Poon; J S Wainscoat; P J Johnson; A M Chang; N M Hjelm
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

10.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

Authors:  S Jahr; H Hentze; S Englisch; D Hardt; F O Fackelmayer; R D Hesch; R Knippers
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

View more
  4 in total

Review 1.  Cell-free fetal nucleic acids in amniotic fluid.

Authors:  L Hui; D W Bianchi
Journal:  Hum Reprod Update       Date:  2010-10-05       Impact factor: 15.610

Review 2.  Tracking fetal development through molecular analysis of maternal biofluids.

Authors:  Andrea G Edlow; Diana W Bianchi
Journal:  Biochim Biophys Acta       Date:  2012-04-19

3.  A comparison of sample collection methods for quantifying cell-free fetal neurodevelopment transcripts in amniotic fluid.

Authors:  Lisa Hui; Stephen Tong; Tu'Uhevaha J Kaitu'u-Lino; Natalie J Hannan
Journal:  BMC Res Notes       Date:  2016-07-07

4.  Maternal obesity affects fetal neurodevelopmental and metabolic gene expression: a pilot study.

Authors:  Andrea G Edlow; Neeta L Vora; Lisa Hui; Heather C Wick; Janet M Cowan; Diana W Bianchi
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.